Samuel Cos
Santander, CB 39011, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer.
Journal: Cancers
Published: January 12, 2024
Melatonin Modulation of Radiation-Induced Molecular Changes in MCF-7 Human Breast Cancer Cells.
Journal: Biomedicines
Published: April 07, 2022
Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments.
Journal: Cancers
Published: May 07, 2021
Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts.
Journal: International journal of molecular sciences
Published: July 11, 2019
Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process.
Journal: Frontiers in physiology
Published: March 27, 2019
Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells.
Journal: International journal of oncology
Published: August 29, 2017
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy.
Journal: Breast cancer (Dove Medical Press)
Published: July 27, 2017
Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells.
Journal: Oncology reports
Published: May 24, 2017
Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF.
Journal: Oncology reports
Published: August 11, 2016
Last Updated: 09/26/2026